Public funding for fundamental research is essential for innovation and the development of new medicines. This is demonstrated by Professor Science Based Business Simcha Jong and his colleague Hsini Huang after studying U.S. federal funding restrictions for stem cell research under President George W. Bush. They published their findings in the July edition of Journal of Management Studies.
* This article was originally published here
